MINIMALLY INVASIVE TUMOR TISSUE PROCUREMENT IS FEASIBLE FOR CLINICAL MANUFACTURING OF OBX-115 ENGINEERED TUMOR-INFILTRATING LYMPHOCYTES (TIL)

C. Bernatchez, P. Balasubramanian, E. N. Cressman, R. Weiser,S. B. Fisher, Y. Chun,M. Forget, D. Sakellariou-Thompson, I. Lai, O. Fulbright,K. Adlerz, C. Khatiwala, G. Wilmes, P. Hari, G. Ramsingh, P. Prabhakar,R. N. Amaria

CYTOTHERAPY（2024）

引用 0|浏览7